SEC Filing Summary: Nanophase Technologies Corporation (10-K)
Business Context and Reporting Period
Company: Nanophase Technologies Corporation (NANX)
Reporting Period: Fiscal year ended December 31, 2004
Business Overview: Nanophase is a developer and commercial manufacturer of nanocrystalline materials (nanoparticles) used in sunscreens, personal care, abrasion-resistant applications, environmental catalysts, and semiconductor polishing (CMP). The company utilizes proprietary Physical Vapor Synthesis (PVS) and NanoArc synthesis technologies. Operations are based in Romeoville and Burr Ridge, Illinois.
Key Financial Metrics (Year Ended Dec 31, 2004)
| Metric | 2004 | 2003 |
|---|---|---|
| Total Revenue | $5,207,934 | $5,446,661 |
| Product Revenue | $4,253,478 | $4,880,313 |
| Other Revenue | $954,456 | $566,348 |
| Cost of Revenue | $5,125,216 | $5,205,065 |
| Gross Profit | $82,718 | $241,596 |
| Net Loss | $(6,446,955) | $(5,827,650) |
| Loss Per Share (Basic/Diluted) | $(0.37) | $(0.38) |
| Cash & Cash Equivalents | $475,185 | $399,999 |
| Investments | $11,155,126 | $4,562,364 |
| Total Liquid Assets (Cash + Investments) | $11,630,311 | $4,962,363 |
| Long-Term Debt | $0 | $263,669 |
| Current Debt Obligations | $579,472 | $1,034,379 |
Note: Gross margin was approximately 1.6% in 2004 compared to 4.4% in 2003. The company reported a cumulative deficit of approximately $52.2 million from inception through 2004.
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 4.4% to $5.21 million. Product revenue dropped 12.8% primarily due to decreased sales of CMP materials to Rohm and Haas Electronic Materials (RHEM). This was partially offset by increased sales to BASF (largest customer) and new sales to Altana Chemie AG.
- Other Revenue Increase: Other revenue increased 68.5% to $954,456, driven largely by $600,000 in technology development funding from RHEM. This offset the absence of a one-time $226,450 equipment sale to C.I. Kasei that occurred in 2003.
- Liquidity Improvement: Total liquid assets (cash and investments) more than doubled to $11.63 million, bolstered by a $10 million equity investment from Altana in March 2004 and $2 million from the exercise of warrants by Grace Brothers, Ltd. in September 2004.
- Debt Reduction: The company paid down long-term debt, leaving only $579,472 in current debt obligations (a promissory note to BASF) as of year-end.
Guidance, Outlook, and Risks
- Strategic Partnerships:
- Altana Chemie AG: Entered a joint development agreement for coatings and sealants. Altana received 1.26 million shares for $10 million. Management expects Altana to become a significant customer in 2006.
- BASF: Remains the largest customer (69.7% of 2004 revenue). The supply agreement includes financial covenants requiring the company to maintain at least $2.0 million in cash/investments to avoid a mandatory transfer of technology and equipment to BASF.
- RHEM: Agreements amended to reduce minimum purchase requirements for 2005, reflecting market timing difficulties in the semiconductor polishing sector.
- Outlook: Management anticipates revenue growth in 2005 from end-user adoption in CMP and fine polishing markets, as well as new sunscreen applications. However, the company expects to continue incurring losses through at least the end of 2005.
- Risks:
- Customer Concentration: Three customers (BASF, RHEM, C.I. Kasei) accounted for approximately 89% of total revenue in 2004. Loss of any major customer would materially harm operations.
- Profitability: Margins are impeded by high fixed manufacturing costs relative to revenue volume. Positive gross margins are not guaranteed in 2005.
- Intellectual Property: A third-party request for re-examination of a key patent (NanoArc Synthesis) is pending with the USPTO.
Investor Verification Checklist
- Covenant Compliance: Verify that cash and investment balances remain above the $2.0 million threshold required by the BASF supply agreement to prevent a forced technology/equipment transfer.
- Customer Concentration: Monitor the stability of revenue from BASF, RHEM, and C.I. Kasei, which collectively represent nearly 90% of sales.
- Patent Status: Track the outcome of the USPTO re-examination of Patent No. 6,669,823 B1 regarding NanoArc Synthesis technology.
- Altana Integration: Assess the timeline and volume of commercial sales to Altana Chemie AG, currently expected to ramp up significantly in 2006.
- Capital Needs: Evaluate whether current cash reserves ($11.6M) are sufficient to fund operations through 2006 without further dilutive equity raises, given the history of annual net losses exceeding $5 million.